Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Mark E. Davis

From Wikipedia, the free encyclopedia
Chemical Engineer
Mark E. Davis
BornOctober 14, 1955[1]
Alma materUniversity of Kentucky
Known forMolecular sieves,Drug delivery
AwardsPrincess of Asturias Award (2014)
E. V. Murphree Award (2005)
Scientific career
FieldsChemical Engineering
InstitutionsCalifornia Institute of Technology
Virginia Tech
Doctoral advisorJohn Yamanis
Doctoral studentsSuzie Pun

Mark E. Davis is the Warren and Katherine SchlingerProfessor ofChemical Engineering at theCalifornia Institute of Technology. He is a member of theCity of Hope National Medical Center. He earned hisB.S.,M.S., andPh.D. inchemical engineering all from theUniversity of Kentucky. His lab focuses on the synthesis of materials for catalysis and biocompatible materials for drug delivery.[2]

Davis was elected as a member into theNational Academy of Engineering in 1997, for pioneering work in the synthesis of new catalytic materials.

Research

[edit]

He did his doctoral work with John Yamanis on reactions engineering with annular bed reactors. His academic career started as an assistant professor atVirginia Polytechnic Institute & State University in 1981 and rose until becoming the Charles O. Gordon Professor of Chemical engineering in 1990. During his time at Virginia Tech, he developed some of the earlierZeolitemolecular sieves and increasing the pore size.[3][4] In 1991, he joined the faculty of theCalifornia Institute of Technology and served as the Executive Officer of the department from 1999 to 2004. In 2004 he joined theCity of Hope National Medical Center, Comprehensive Cancer Center.[5]

In 1995, his wife, Mary, was diagnosed with breast cancer and had to go through chemotherapy. Having seen the side effects of cancer treatment, he decided to do research on molecules that would prevent drug from leaking through healthy blood vessels but would stop at the tumor. His group conjugatedcyclodextrin to the anti-cancer compoundcamptothecin to improve the bio-availability and exhibit efficacy in mouse tumor models.[6] The compound,CRLX101 is now being tested in clinical trials.[7]The cyclodextrin nanoparticles are also being used to encapsulate siRNA.

He was the recipient of theAlan T. Waterman Award in 1990. In 1997, he was elected to theNational Academy of Engineering, in 2006, to theNational Academy of Sciences, and in 2011, theNational Academy of Medicine.[8] He is also the founder of Insert Therapeutics and Calando Pharmaceuticals.

Personal

[edit]

Mark was born in Ellwood City, Pennsylvania, as the son of teachers of history and English.[5]Mark Davis is an accomplished athlete and was on a full scholarship in track and field at theUniversity of Kentucky. He is the 400-Meter World Champion for the 55–59 division. He was also part of the USA 4x100 and 4x400 meter teams.[9] He met his wife Mary while a professor atVirginia Tech.[7] She was an accomplishedflautist before being diagnosed with breast cancer.[5]

References

[edit]
  1. ^"Avelino Corma Canós, Mark E. Davis and Galen D. Stucky, Prince of Asturias Award for Technical and Scientific Research - Communication".
  2. ^"Mark E. Davis". Caltech. Archived fromthe original on 14 April 2019. Retrieved7 April 2013.
  3. ^Arhancet, Juan P.; Davis, Mark E.; Merola, Joseph S.; Hanson, Brian E. (8 June 1989). "Hydroformylation by supported aqueous-phase catalysis: a new class of heterogeneous catalysts".Nature.339 (6224):454–455.Bibcode:1989Natur.339..454A.doi:10.1038/339454a0.S2CID 34932513.
  4. ^Davis, Mark E.; Saldarriaga, Carlos; Montes, Consuelo; Garces, Juan; Crowdert, Cyrus (25 February 1988). "A molecular sieve with eighteen-membered rings".Nature.331 (6158):698–699.Bibcode:1988Natur.331..698D.doi:10.1038/331698a0.S2CID 26623258.
  5. ^abcAhmed, F (Dec 26, 2007)."Profile of Mark E. Davis".Proceedings of the National Academy of Sciences of the United States of America.104 (52):20651–3.Bibcode:2007PNAS..10420651A.doi:10.1073/pnas.0704959105.PMC 2409208.PMID 18093958.
  6. ^Schluep, T. (1 March 2006)."Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models".Clinical Cancer Research.12 (5):1606–1614.doi:10.1158/1078-0432.CCR-05-1566.PMID 16533788.
  7. ^abGellene, Denise (11 August 2007)."Science begins at home".LA Times. Retrieved7 April 2013.
  8. ^"Professor Mark E Davis".
  9. ^Fesenmaier, Kimm (28 July 2011)."Caltech Professor Runs to Victories on the World Stage".Caltech News. Retrieved7 April 2013.

External links

[edit]
Laureates of thePrince or Princess of Asturias Award for Technical and Scientific Research
Prince of Asturias Award for Technical and Scientific Research
Princess of Asturias Award for Technical and Scientific Research
International
National
Academics
Other
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mark_E._Davis&oldid=1321832377"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp